Unlocking Potential: Big Pharma Execs Embrace Biotech Opportunities
)
)
In recent years, we have seen a flurry of Big Pharma executives transition into Biotech CEO positions. The opportunity to work in a more agile and entrepreneurial environment, whilst driving a transformative mission centred around innovation and patient care, continues to prove an attraction. We are fortunate to see these qualities every day in many of the Biotechs we work alongside.
GSK’s Chief Scientific Officer, Hal Barron, announced last month that he will be stepping down and joining Altos Labs later this year.Altos Labsis an innovative Biotech start-up with $3B in funding and a focus on reversing disease and the ageing process. The movement of Big Pharma executive talent into early-stage Biotech is becoming a growing trend, and something that Venari Partners is closely associated with.
Our Director, Life Sciences & Healthcare,Ben Brickell, takes a look at what is attracting experienced leaders to jump from Big Pharma to Biotech.
Swipe to learn more about their move toAltos Labs,Galapagos,Eikon Therapeutics,Karyopharm Therapeutics Inc.,AlloVir,Kite Pharma,Atara Biotherapeutics,Enzyvant,Forma Therapeutics
Tags:
- Insight
- Market Update
- Leadership
)
Cristian joined Venari Partners in 2019 and is a core member of the Life Sciences & Healthcare practice. He is hugely passionate about the Digital Health space, and the partner of choice to many emerging and high-growth HealthTech companies across the US & Europe. With over 6 years of experience headhunting global leaders within the Digital Health industry, Cristian helps organisations identify, attract, and retain the best Strategy, Business Development, Operations and Commercial talent around the world. Typical growth scenarios he supports include: - US GTM Expansion for European HealthTech companies - Commercial buildout, due to successful fundraising or product launch (US or EU) - CEO selection to replace a Founder who is looking to transition into a CTO/NED role. - Board level appointments Chairman, non-executive advisory etc. Retained executive recruitment is a core discipline, but the team is also equipped to provide expert Diversity, Equity, and Inclusion (DEI) mapping solutions, Interim & Consulting solutions, Board Advisory, Market Mapping, Compensation Benchmarking, and Leadership & Organisational Assessment. Outside of Venari Partners, as a former chef, he has a tremendous passion for food and loves to experiment with cooking and eating as many different cuisines as possible.
View Full Profile)
)
)
)
)
